Internal Medicine, Infectious Disease · Jacksonville, FL
NPI
1598963290
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
820 Prudential Dr Ste 515, Credentialing Department
Jacksonville, FL, 32207
Phone (904) 396-4886
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
2,560 services
Medicare patients, 2024
462
Average age 73
Drug cost, 2024
$711K
940 prescriptions
Company payments, 2025
$1,214
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Man-Kuang Chang was code 99232 (hospital e&m - subsequent), 1,221 times for 282 patients. In total Man-Kuang Chang billed 2,560 services in 14 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,221 | 282 | $61.55 | $75K |
| 99233 Hospital E&M - Subsequent | Facility | 708 | 206 | $91.74 | $65K |
| 99223 Hospital E&M - Initial | Facility | 276 | 254 | $133.80 | $37K |
| 99214 Office E&M - Established | Office | 235 | 158 | $94.10 | $22K |
| 99222 Hospital E&M - Initial | Facility | 52 | 47 | $103.59 | $5,387 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 25 | 22 | $39.95 | $999 |
| 99204 Office E&M - New | Office | 19 | 19 | $130.19 | $2,474 |
| 99215 Office E&M - Established | Office | 13 | 11 | $115.45 | $1,501 |
By year: 2022 $210K for 2,771 services; 2023 $190K for 2,353 services; 2024 $211K for 2,560 services.
Medicare prescription drug claims, 2024
In 2024, the drug Man-Kuang Chang prescribed most often to Medicare patients was Daptomycin, with 117 prescriptions and refills. In total Man-Kuang Chang wrote 940 Medicare prescriptions that cost $711K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 117 | 117 | 28 | $76K |
| Vancomycin Hcl Generic | 110 | 118 | 43 | $11K |
| Meropenem Generic | 95 | 95 | 19 | $11K |
| Ertapenem Ertapenem Sodium | 59 | 59 | 23 | $23K |
| Ceftazidime Generic | 47 | 47 | 13 | $7,351 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 40 | 40 | Under 11 | $156K |
| Cefepime Hcl Generic | 37 | 37 | 12 | $5,117 |
| Ceftriaxone Ceftriaxone Sodium | 34 | 34 | 14 | $1,442 |
| Ciprofloxacin Hcl Generic | 22 | 28 | 13 | $507 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 19 | 19 | Under 11 | $74K |
| Cefdinir Generic | 19 | 23 | 14 | $900 |
| Cabenuva Cabotegravir/Rilpivirine | 17 | 17 | Under 11 | $98K |
| Fosfomycin Tromethamine Generic | 17 | 19 | Under 11 | $8,875 |
| Doxycycline Hyclate Generic | 15 | 24 | 12 | $408 |
| Levofloxacin Generic | 14 | 22 | Under 11 | $190 |
Brand drugs: 168 claims; generic drugs: 772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Man-Kuang Chang $1,214 ($1,214 in general payments such as food, travel and fees) from 11 companies. The largest payer was Merck Sharp & Dohme LLC with $295.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 11 | $295 |
| Gilead Sciences, Inc. GILD | 9 | $215 |
| Aimmune Therapeutics, Inc. | 7 | $174 |
| ViiV Healthcare Company GSK | 5 | $145 |
| Paratek Pharmaceuticals, Inc. | 4 | $80.13 |
| Insmed, Inc. INSM | 3 | $75.89 |
| Melinta Therapeutics, LLC | 3 | $64.38 |
| Pfizer Inc. PFE | 2 | $50.75 |
| Theratechnologies Inc. THTX | 1 | $48.58 |
| Abbvie Inc. ABBV | 2 | $47.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.